ePrints

Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia: A study by the I-BFM-SG.

Lookup NU author(s): Professor Christine Harrison

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): van Weelderen RE, Klein K, Harrison CJ, Jiang Y, Abrahamsson J, Arad Cohen N, Bart Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gerbing RB, Goemans BF, de Groot Kruseman HA, Guest E, Ha SY, Hasle H, Jackson K, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Masetti R, Miyamura T, Norén Nyström U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan CM, Kaspers GJL

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Oncology

Year: 2023

Volume: 41

Issue: 16

Pages: 2963-2974

Print publication date: 01/06/2023

Online publication date: 30/03/2023

Acceptance date: 01/02/2023

Date deposited: 12/12/2024

ISSN (print): 0732-183X

ISSN (electronic): 1527-7755

Publisher: American Society of Clinical Oncology

URL: https://doi.org/10.1200/JCO.22.02120

DOI: 10.1200/JCO.22.02120

Data Access Statement: Individual participant data are not available to share. Participating study groups should be contacted directly for the original data

Altmetrics

Share